Evidence map›Paper›PMID 25896788›Full record

ArticleBMC nephrology2015

Protein-bound solute removal during extended multipass versus standard hemodialysis.

Sunny Eloot, Wim Van Biesen, Mette Axelsen, Griet Glorieux, Robert Smith Pedersen, James Goya Heaf

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in BMC nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01267760 (Clinical and Biochemical Effects of Multipass Hemodialysis), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01267760 phase2completednot on this map

Clinical and Biochemical Effects of Multipass Hemodialysis

TypeinterventionalSponsorHerlev HospitalRan2011 to 2011Enrolled12ConditionsUremiaArmsMultipass hemodialysis
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sunny ElootDepartment of Nephrology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. sunny.eloot@ugent.be.
Wim Van BiesenDepartment of Nephrology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. wim.vanbiesen@ugent.be.
Mette AxelsenInstitute of Public Health, Aarhus University, Nordre Ringgade 1, 8000, Aarhus C, Denmark. metaxels@rm.dk.
Griet GlorieuxDepartment of Nephrology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. griet.glorieux@ugent.be.
Robert Smith PedersenFlexdialysis Aps, Copenhagen, Denmark.
James Goya HeafDepartment of Nephrology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. d110582@dadlnet.dk.
Ghent University Hospital · BEAarhus University · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultipass hemodialysis (MPHD) is a recently described dialysis modality, involving the use of small volumes of dialysate which are repetitively recycled. Dialysis regimes of 8 hours for six days a week using this device result in an increased removal of small water soluble solutes and middle molecules compared to standard hemodialysis (SHD). Since protein-bound solutes (PBS) exert important pathophysiological effects, we investigated whether MPHD results in improved removal of PBS as well.

methodsA cross-over study (Clinical Trial NCT01267760) was performed in nine stable HD patients. At midweek a single dialysis session was performed with either 4 hours SHD using a dialysate flow of 500 mL/min or 8 hours MPHD with a dialysate volume of 50% of estimated body water volume. Blood and dialysate samples were taken every hour to determine concentrations of p-cresylglucuronide (PCG), hippuric acid (HA), indole acetic acid (IAA), indoxyl sulfate (IS), and p-cresylsulfate (PCS). Dialyser extraction ratio, reduction ratio, and solute removal were calculated for these solutes.

resultsAlready at 60 min after dialysis start, the extraction ratio in the hemodialyser was a factor 1.4-4 lower with MPHD versus SHD, resulting in significantly smaller reduction ratios and lower solute removal within a single session. Even when extrapolating our findings to 3 times 4 h SHD and 6 times 8 h MPHD per week, the latter modality was at best similar in terms of total solute removal for most protein-bound solutes, and worse for the highly protein-bound solutes IS and PCS. When efficiency was calculated as solute removal/litre of dialysate used, MPHD was found superior to SHD.

conclusionWhen high water consumption is a concern, a treatment regimen of 6 times/week 8 h MPHD might be an alternative for 3 times/week 4 h SHD, but at the expense of a lower total solute removal of highly protein-bound solutes.

Indexed as

Appointments and SchedulesHemodialysis SolutionsProteinsAgedCross-Over StudiesFemaleHumansKidney Failure, ChronicMaleMiddle AgedPrognosisRenal DialysisTime FactorsTreatment OutcomeUltrafiltrationUreaHemodialysis SolutionsProteinsUreaUric Acid

Identifiers

PMID25896788
PMCPMC4404563
OpenAlexW1979055762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.